References
1. Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford
SC, et al. Medulloblastoma. Nat Rev Dis Primers. 2019 14;5(1):11.
2. Packer RJ, Vezina G. Management of and prognosis with
medulloblastoma: therapy at a crossroads. Arch Neurol. 2008
Nov;65(11):1419–24.
3. Lafay–Cousin L, Bouffet E, Hawkins C, Amid A, Huang A, Mabbott DJ.
Impact of radiation avoidance on survival and neurocognitive outcome in
infant medulloblastoma. Curr Oncol. 2009 Dec;16(6):21–8.
4. Palmer SL, Reddick WE, Gajjar A. Understanding the Cognitive Impact
on Children Who are Treated for Medulloblastoma. J Pediatr Psychol. 2007
Oct 1;32(9):1040–9.
5. Ning MS, Perkins SM, Dewees T, Shinohara ET. Evidence of high
mortality in long term survivors of childhood medulloblastoma. J
Neurooncol. 2015 Apr 1;122(2):321–7.
6. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late
neurocognitive sequelae in survivors of brain tumours in childhood.
Lancet Oncol. 2004 Jul;5(7):399–408.
7. Rodriguez-Galindo C, Friedrich P, Morrissey L, Frazier L. Global
challenges in pediatric oncology. Curr Opin Pediatr. 2013
Feb;25(1):3–15.
8. Parkes J, Hendricks M, Ssenyonga P, Mugamba J, Molyneux E,
Schouten-van Meeteren A, et al. SIOP PODC adapted treatment
recommendations for standard-risk medulloblastoma in low and middle
income settings. Pediatr Blood Cancer. 2015 Apr;62(4):553–64.
9. Gajjar A, Finlay JL. The management of children and adolescents with
medulloblastoma in low and middle income countries. Pediatric Blood &
Cancer. 2015;62(4):549–50.
10. Ezzat S, Kamal M, El-Khateeb N, El-Beltagy M, Taha H, Refaat A, et
al. Pediatric brain tumors in a low/middle income country: does it
differ from that in developed world? J Neurooncol. 2016 Jan
1;126(2):371–6.
11. Azad TD, Shrestha RK, Vaca S, Niyaf A, Pradhananga A, Sedain G, et
al. Pediatric Central Nervous System Tumors in Nepal: Retrospective
Analysis and Literature Review of Low- and Middle-Income Countries.
World Neurosurgery. 2015 Dec 1;84(6):1832–7.
12. Dressler EV, Dolecek TA, Liu M, Villano JL. Demographics, Patterns
of Care, and Survival in Pediatric Medulloblastoma. J Neurooncol. 2017
May;132(3):497–506.
13. Baskin JL, Lezcano E, Kim BS, Figueredo D, Lassaletta A,
Perez-Martinez A, et al. Management of children with brain tumors in
Paraguay. Neuro-oncology. 2013 Feb;15(2):235–41.
14. Flores LE, Williams DL, Bell BA, O’Brien M, Ragab AH. Delay in the
Diagnosis of Pediatric Brain Tumors. Am J Dis Child. 1986 Jul
1;140(7):684–6.
15. Kukal K, Dobrovoljac M, Boltshauser E, Ammann RA, Grotzer MA. Does
diagnostic delay result in decreased survival in paediatric brain
tumours? Eur J Pediatr. 2009 Mar 1;168(3):303–10.
16. Shay V, Fattal-Valevski A, Beni-Adani L, Constantini S. Diagnostic
delay of pediatric brain tumors in Israel: a retrospective risk factor
analysis. Childs Nerv Syst. 2012 Jan 1;28(1):93–100.
17. Brazil | Data [Internet]. [cited 2019 Jul 8].
Available from: https://data.worldbank.org/country/brazil
18. Institucional [Internet]. INCA - Instituto Nacional de Câncer.
2018 [cited 2019 Jul 8]. Available from:
https://www.inca.gov.br/institucional
19. Ferman S, Lima FF da S, Lage CRS, da Hora SS, Vianna DT, Thuler LC.
Preventing treatment abandonment for children with solid tumors: A
single-center experience in Brazil. Pediatr Blood Cancer. 2019
Jul;66(7):e27724.
20. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson
PL, et al. Phase III Study of Craniospinal Radiation Therapy Followed by
Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
JCO. 2006 Sep 1;24(25):4202–8.
21. Santos MA, Viégas CMP, Servidoni RA, Barros MHM, Pinel MI, Araújo
CMM. Timing of radiation in children with medulloblastoma/PNET. Pediatr
Blood Cancer. 2007 Apr;48(4):416–22.
22. Bleil CB, Bizzi JWJ, Bedin A, de Oliveira FH, Antunes ÁCM. Survival
and prognostic factors in childhood medulloblastoma: A Brazilian single
center experience from 1995 to 2016. Surg Neurol Int [Internet].
2019 Jun 25 [cited 2020 May 6];10. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744760/
23. Johnston DL, Keene D, Kostova M, Lafay-Cousin L, Fryer C,
Scheinemann K, et al. Survival of children with medulloblastoma in
Canada diagnosed between 1990 and 2009 inclusive. J Neurooncol. 2015
Sep;124(2):247–53.
24. Kombogiorgas D, Sgouros S, Walsh AR, Hockley AD, Stevens M, Grundy
R, et al. Outcome of children with posterior fossa medulloblastoma: a
single institution experience over the decade 1994-2003. Childs Nerv
Syst. 2007 Apr;23(4):399–405.
25. Urberuaga A, Navajas A, Burgos J, Pijoán JI. A review of clinical
and histological features of Spanish paediatric medulloblastomas during
the last 21 years. Childs Nerv Syst. 2006 May;22(5):466–74.
26. Igual Estellés L, Berlanga Charriel P, Cañete Nieto A.
Meduloblastoma: mejoría de la supervivencia en las últimas décadas.
Experiencia de un centro. Anales de Pediatría. 2017 Jan 1;86(1):4–10.
27. Chan M-Y, Teo W-Y, Seow W-T, Tan A-M. Epidemiology, management and
treatment outcome of medulloblastoma in singapore. Ann Acad Med Singap.
2007 May;36(5):314–8.
28. Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ,
Due-Tønnessen P, Kepka A, et al. Children treated for medulloblastoma
and supratentorial primitive neuroectodermal tumor in Norway from 1974
through 2013: Unexplainable regional differences in survival. Pediatr
Blood Cancer. 2019 Jul 1;e27910.
29. Wong T-T, Liu Y-L, Ho DM-T, Chang K-P, Liang M-L, Chen H-H, et al.
Factors affecting survival of medulloblastoma in children: the changing
concept of management. Childs Nerv Syst. 2015 Oct;31(10):1687–98.
30. Chen S-H, Liu L-Y, Jaing T-H, Tseng C-K, Lin K-L, Lui T-N.
Multivariate survival analysis of children with medulloblastoma–a
single-center experience. Pediatr Hematol Oncol. 2008 Sep;25(7):647–54.
31. Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali
S, Castillo L, et al. Toward the Cure of All Children With Cancer
Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.
J Clin Oncol. 2015 Sep 20;33(27):3065–73.
32. Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, et al.
Feasibility and Response to Induction Chemotherapy Intensified With
High-Dose Methotrexate for Young Children With Newly Diagnosed High-Risk
Disseminated Medulloblastoma. JCO. 2004 Dec 15;22(24):4881–7.
33. von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M,
Deinlein F, et al. Treatment of young children with localized
medulloblastoma by chemotherapy alone: Results of the prospective,
multicenter trial HIT 2000 confirming the prognostic impact of
histology. Neuro Oncol. 2011 Jun;13(6):669–79.
34. Quilty R. Mind the Gap: Improving Pediatric Cancer Care in
Developing Countries. University of Ottawa Journal of Medicine. 2016 Nov
30;6(2):40–2.